Skip to main content
HERON THERAPEUTICS, INC. /DE/ logo

HERON THERAPEUTICS, INC. /DE/ — Investor Relations & Filings

Ticker · HRTX ISIN · US4277461020 LEI · 549300DR2I1DOPD2IX53 US Manufacturing
Filings indexed 1,030 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country US United States of America
Listing US HRTX

About HERON THERAPEUTICS, INC. /DE/

https://www.herontx.com/

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on developing and commercializing therapies to address unmet medical needs in acute care and oncology. The company utilizes its proprietary drug delivery technologies to create novel, best-in-class treatments. Its product portfolio is designed to improve the lives of patients by providing solutions for significant medical issues, including postoperative pain management, with an aim to reduce opioid reliance, as well as managing postoperative and chemotherapy-induced nausea and vomiting.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 85% confidence The document is a Current Report on Form 8-K filed with the SEC detailing a material legal event (patent litigation decision and related press release). It does not present full financial statements or quarterly results, nor does it match any specific categories like earnings release, proxy materials, or M&A filings. As a standard SEC compliance report registering an event under the Exchange Act, it falls under the general Regulatory Filings category.
2026-06-02 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-05-13 English
10-Q - HERON THERAPEUTICS, INC. /DE/ (0000818033) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-11 English
8-K - HERON THERAPEUTICS, INC. /DE/ (0000818033) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC under the Exchange Act, furnishing an earnings press release as Exhibit 99.1. This is a regulatory filing rather than the earnings release itself or a standalone financial report. Therefore, it falls under the general “Regulatory Filings” category.
2026-05-11 English
ARS - HERON THERAPEUTICS, INC. /DE/ (0000818033) (Filer)
Annual Report
2026-04-30 English
DEFA14A
Proxy Solicitation & Information Statement
2026-04-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.